qs_id,statement_number,statement
QS9,1,Adults with suspected chronic heart failure who have been referred for diagnosis have an echocardiogram and specialist assessment.
QS9,2,"Adults with suspected chronic heart failure and very high levels of serum natriuretic peptides, who have been referred for diagnosis, have an echocardiogram and specialist assessment within 2 weeks."
QS9,3,Adults with chronic heart failure who have reduced ejection fraction are started on low‑dose angiotensin‑converting enzyme (ACE) inhibitor and beta‑blocker medications that are gradually increased until the target or optimal tolerated doses are reached.
QS9,4,Adults with chronic heart failure have a review within 2 weeks of any change in the dose or type of their heart failure medication.
QS9,5,Adults with stable chronic heart failure have a review of their condition at least every 6 months.
QS9,6,Adults with stable chronic heart failure are offered an exercise‑based programme of cardiac rehabilitation.
QS9,7,"Developmental quality statements set out an emergent area of cutting‑edge service delivery or technology currently found in a minority of providers and indicating outstanding performance. They will need specific, significant changes to be put in place, such as redesign of services or new equipment."
